Puma Biotechnology (PBYI) Raw Materials (2020 - 2026)

Puma Biotechnology (PBYI) has 7 years of Raw Materials data on file, last reported at $6.0 million in Q1 2026.

• Quarterly Raw Materials fell 15.77% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (down 15.77% YoY) and the FY2025 annual result came in at $3.2 million, down 55.28% from the prior year.
• Raw Materials advanced to $6.0 million in Q1 2026, from $3.2 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $7.2 million in Q4 2024 to a low of $211000.0 in Q3 2024.
• A 5-year average of $3.7 million and a median of $3.6 million in 2025 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2024 — Raw Materials tumbled 83.74% — and 2025, when it soared 1626.07%.
• Tracing PBYI's Raw Materials over 5 years: stood at $1.7 million in 2022, then soared by 239.07% to $5.7 million in 2023, then gained by 26.17% to $7.2 million in 2024, then sank by 55.28% to $3.2 million in 2025, then jumped by 86.74% to $6.0 million in 2026.
• The last three Raw Materials figures came in at $6.0 million (Q1 2026), $3.2 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.